Invention Publication
- Patent Title: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF TRANSTHYRETIN
-
Application No.: US17721704Application Date: 2022-04-15
-
Publication No.: US20230257740A1Publication Date: 2023-08-17
- Inventor: Dinah Wen-yee Sah , Gregory Hinkle , Rene Alvarez , Stuart Milstein , Qingmin Chen
- Applicant: Alnylam Pharmaceuticals, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Alnylam Pharmaceuticals, Inc.
- Current Assignee: Alnylam Pharmaceuticals, Inc.
- Current Assignee Address: US MA Cambridge
- Main IPC: C12N15/113
- IPC: C12N15/113 ; C12N15/11 ; C07F9/6533 ; C07H21/04 ; A61K9/00 ; A61K31/713
Abstract:
The invention relates to a double-stranded ribonucleic acid (dsRNA) targeting a transthyretin (TTR) gene, and methods of using the dsRNA to inhibit expression of TTR.
Public/Granted literature
- US12227744B2 Compositions and methods for inhibiting expression of transthyretin Public/Granted day:2025-02-18
Information query
IPC分类:
